🏛️ The Patent Paradox That Shocked India

🌟 Imagine creating a life-saving cancer drug, getting a patent, but then pricing it so high that the people who need it most can't afford it. What happens when innovation meets desperation?

💡 What You'll Discover:

• 🔍 Why getting a patent isn't just about being "new" - it must be useful AND accessible
• ⚖️ The shocking difference between importing drugs vs. actually making them locally
• 🎯 How compulsory licensing works as a "safety valve" when patents go wrong
• 💰 What "reasonably affordable" actually means in patent law

🚀 Real Cases Discussed:

• 💎 Bayer Corporation vs. Union of India (2014) - The Bombay High Court case that changed everything
• ⭐ Vishwanath Prasad Radheshyam case - Supreme Court's foundational ruling on patent utility
• 🏥 The Nexavar cancer drug controversy - when a life-saving medicine becomes a luxury item

🎪 The David vs. Goliath Story:

• 🌍 Bayer: Global pharma giant with expensive cancer drug Sorafenib Tosylate (Nexavar)
• 🇮🇳 Natco Pharma: Indian generic company fighting for affordable access
• ⚡ Section 84 of Patent Act 1970: The legal weapon that leveled the playing field

🎙️ This isn't just a legal battle - it's about the fundamental question of whether life-saving innovations should be accessible to everyone, not just the wealthy!